FDC Ltd share price remained flat to Rs 403.0. The Company's net profit soared by 28.13% to Rs 132.49 crore, while revenue from operations gained 14.18% to Rs 667.69 crore in Q2FY26 over Q1FY26. The market capitalization of Pharmaceuticals industry group stocks on BSE stood at Rs 24.82 lakh crore, rising 5.74%. It has marginally improved by 0.41% over last one week and advanced by 11.45% in last one month while the market capitalization of FDC Ltd has eased by 2.73% and 7.34% in the same period respectively. Profit before tax (PBT) of FDC Ltd stood at Rs 174.7 crore in Q2 FY26, easing 9.34% year-on-year, and jumping 24.47% quarter-on-quarter. EBITDA came in at Rs 95 crore, slipping 9.08% YoY and surging by 68.80% sequentially. Total expenses grew marginally by 9.55% to Rs 539.82 crore in Q2FY26 over Q2FY25. During the quarter, cost of materials consumed stood at Rs 144.5 crore, marginally falling by 2.97% YoY, while employee benefits expense was at Rs 135.16 crore, surging 23.66% YoY. For the TTM ended FY26, revenue from operations posted a slight growth of 8.50% to Rs 2108.12 crore, while net profit dropped 12.55% to Rs 266.79 crore, compared to previous TTM. EBITDA surged by 24972% to Rs 234.14 crore, and PBT saw a marginal contraction of 9.84% to Rs 357.22 crore compared to previous TTM. The company's consolidated net cash flow from operating activities stood at Rs 317.57 crore in FY26, as against Rs 220.77 crore in FY25. FDC Ltd nosedived by 16.33% in last one year, underperforming the benchmark BSE Sensex which has eased by 3.20% during the same period.
